Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date The Omic Revolution: Leveraging Multiomic Integration... Michael Ritchie, PhD, MBA The era of leveraging genomics and transcriptomics has yielded a deeper understanding of the molecular underpinnings of neoplastic transformation and ... 3 months ago | 50 mins Using the Lumin Platform to Build Prediction Models of Olaparib Sensitivity Day2 Clare Killick-Cole, PhD & Art Hanson, MSCS Day 2: Enriching your Multi-omic Dataset and Building Highly Predictive Models of Response Sensitivity Learn more about these topics by registering ... 8 months ago | 48 mins Next Generation Humanized Mice for AML and NK Cell Therapy Testing Amy Wesa, PhD, Director of Immuno-Oncology Research at Champions Oncology To develop the most successful novel agents for cancer, researchers require preclinical models that fundamentally epitomize patient populations to ena... 3 years ago | 56 mins Building Oncology Biomarker Programs using Sequencing & Computational Discovery Michael Ritchie, PhD, MBA, Chief Commercial Officer, Champions Oncology Tumor volume measurements represent a single and superficial dimension of the information that can be collected during a preclinical pharmacology stud... 2 years ago | 50 mins Next Generation Humanized Mice for AML and NK Cell Therapy Testing Amy Wesa, PhD, Director of Immuno-Oncology Research at Champions Oncology To develop the most successful novel agents for cancer, researchers require preclinical models that fundamentally epitomize patient populations to ena... 3 years ago | 55 mins Advanced Hematology Oncology PDX Tumor Biology Platforms for Drug Advancement Neal Goodwin, PhD, Vice President of Research Development Champions Oncology has established an advanced PDX platform for modeling hematology oncology malignancies, including AML and ALL. The resource consist... 3 years ago | 45 mins
